Skip to main content
Top
Published in:

01-10-2019 | Hyperparathyroidism | Case report

Etelcalcetide

Gastrointestinal disorders and hypocalcaemia: 2 case reports

Published in: Reactions Weekly | Issue 1/2019

Login to get access

Excerpt

In an observational study, two patients [ages and sexes not stated] were described, who developed gastrointestinal disorder (one patient) and symptomatic hypocalcaemia (one patient) during treatment with IV etelcalcetide 5mg thrice weekly for severe secondary hyperparathyroidism. Both the patients were on dialysis. The treatment with etelcalcetide was discontinued in both the patients [duration of treatment to reactions onset and outcomes not stated]. …
Literature
go back to reference Russo D, et al. Etelcalcetide in patients on hemodialysis with severe secondary hyperparathyroidism. Multicenter study in "real life". Journal of Clinical Medicine 8: 1066, No. 7, Jul 2019. Available from: URL: http://doi.org/10.3390/jcm8071066 - Italy Russo D, et al. Etelcalcetide in patients on hemodialysis with severe secondary hyperparathyroidism. Multicenter study in "real life". Journal of Clinical Medicine 8: 1066, No. 7, Jul 2019. Available from: URL: http://​doi.​org/​10.​3390/​jcm8071066 - Italy
Metadata
Title
Etelcalcetide
Gastrointestinal disorders and hypocalcaemia: 2 case reports
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-69905-x